Ole Jensen

912 total citations
22 papers, 321 citations indexed

About

Ole Jensen is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ole Jensen has authored 22 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 7 papers in Pharmacology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ole Jensen's work include Drug Transport and Resistance Mechanisms (16 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Ole Jensen is often cited by papers focused on Drug Transport and Resistance Mechanisms (16 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Ole Jensen collaborates with scholars based in Germany, Sweden and Israel. Ole Jensen's co-authors include Jürgen Brockmöller, Mladen V. Tzvetkov, Muhammad Rafehi, Johannes Matthaei, Thomas Prukop, N. Arul Murugan, Matthias Schwab, Frank Faltraco, Ulrich Krings and Stefan Viktor Vormfelde and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Ole Jensen

22 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ole Jensen Germany 14 196 88 80 66 61 22 321
Joao N.S. Pereira Germany 7 257 1.3× 74 0.8× 169 2.1× 65 1.0× 62 1.0× 8 427
Akihiro Inano Japan 10 162 0.8× 69 0.8× 113 1.4× 54 0.8× 55 0.9× 13 359
Ali R. Saadatmand Germany 10 245 1.3× 103 1.2× 184 2.3× 57 0.9× 61 1.0× 12 501
Hélène Chapy France 13 164 0.8× 98 1.1× 92 1.1× 31 0.5× 42 0.7× 16 347
Gregory Kaler United States 7 308 1.6× 184 2.1× 145 1.8× 77 1.2× 45 0.7× 13 510
Renato J. Scialis United States 15 295 1.5× 98 1.1× 144 1.8× 25 0.4× 52 0.9× 24 502
Naotoshi Yamamura Japan 11 116 0.6× 157 1.8× 82 1.0× 21 0.3× 90 1.5× 35 479
Lucy Sasongko Indonesia 10 336 1.7× 65 0.7× 285 3.6× 30 0.5× 60 1.0× 26 549
Vincent Tong Canada 12 91 0.5× 192 2.2× 303 3.8× 75 1.1× 30 0.5× 20 647
Philip Worboys United Kingdom 13 168 0.9× 143 1.6× 61 0.8× 18 0.3× 84 1.4× 14 558

Countries citing papers authored by Ole Jensen

Since Specialization
Citations

This map shows the geographic impact of Ole Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Jensen more than expected).

Fields of papers citing papers by Ole Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Jensen. The network helps show where Ole Jensen may publish in the future.

Co-authorship network of co-authors of Ole Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Jensen. A scholar is included among the top collaborators of Ole Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Jensen. Ole Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jensen, Ole, et al.. (2024). Comprehensive characterization of the OCT1 phenylalanine-244-alanine substitution reveals highly substrate-dependent effects on transporter function. Journal of Biological Chemistry. 300(11). 107835–107835. 1 indexed citations
2.
Jensen, Ole, et al.. (2023). Combined and independent effects of OCT1 and CYP2D6 on the cellular disposition of drugs. Biomedicine & Pharmacotherapy. 161. 114454–114454. 3 indexed citations
3.
Jensen, Ole, et al.. (2022). Substrates and Inhibitors of the Organic Cation Transporter 3 and Comparison with OCT1 and OCT2. Journal of Medicinal Chemistry. 65(18). 12403–12416. 21 indexed citations
4.
Jensen, Ole, et al.. (2022). The mystery of the human proton-organic cation antiporter: One transport protein or many?. Pharmacology & Therapeutics. 239. 108283–108283. 13 indexed citations
5.
Jensen, Ole, et al.. (2022). Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities. International Journal of Molecular Sciences. 23(15). 8430–8430. 9 indexed citations
6.
Jensen, Ole, et al.. (2022). Atypical Substrates of the Organic Cation Transporter 1. Biomolecules. 12(11). 1664–1664. 16 indexed citations
7.
Jensen, Ole, et al.. (2022). Relationships between Inhibition, Transport and Enhanced Transport via the Organic Cation Transporter 1. International Journal of Molecular Sciences. 23(4). 2007–2007. 17 indexed citations
8.
Jensen, Ole, et al.. (2021). Identification of Novel High-Affinity Substrates of OCT1 Using Machine Learning-Guided Virtual Screening and Experimental Validation. Journal of Medicinal Chemistry. 64(5). 2762–2776. 25 indexed citations
9.
Murugan, N. Arul, et al.. (2021). Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2. Biochemical Pharmacology. 197. 114871–114871. 13 indexed citations
10.
Matthaei, Johannes, Jürgen Brockmöller, Werner Steimer, et al.. (2021). Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients. Frontiers in Pharmacology. 12. 688950–688950. 17 indexed citations
11.
Jensen, Ole, et al.. (2021). Isobutyrylcarnitine as a Biomarker of OCT1 Activity and Interspecies Differences in its Membrane Transport. Frontiers in Pharmacology. 12. 674559–674559. 20 indexed citations
12.
Jensen, Ole, et al.. (2021). How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter. Biochemical Pharmacology. 192. 114751–114751. 10 indexed citations
13.
Jensen, Ole, et al.. (2021). Overlap and Specificity in the Substrate Spectra of Human Monoamine Transporters and Organic Cation Transporters 1, 2, and 3. International Journal of Molecular Sciences. 22(23). 12816–12816. 16 indexed citations
14.
Jensen, Ole, et al.. (2021). Cellular Uptake of Psychostimulants – Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?. Frontiers in Pharmacology. 11. 609811–609811. 18 indexed citations
15.
Jensen, Ole, et al.. (2020). A double-Flp-in method for stable overexpression of two genes. Scientific Reports. 10(1). 14018–14018. 8 indexed citations
16.
Jensen, Ole, et al.. (2019). Variability and Heritability of Thiamine Pharmacokinetics With Focus on OCT1 Effects on Membrane Transport and Pharmacokinetics in Humans. Clinical Pharmacology & Therapeutics. 107(3). 628–638. 19 indexed citations
17.
Büttner, Benedikt, José Hinz, Ayelet Alpert, et al.. (2019). CTLA-4 Genetic Variants Predict Survival in Patients with Sepsis. Journal of Clinical Medicine. 8(1). 70–70. 17 indexed citations
18.
Rafehi, Muhammad, Frank Faltraco, Johannes Matthaei, et al.. (2019). Highly Variable Pharmacokinetics of Tyramine in Humans and Polymorphisms in OCT1, CYP2D6, and MAO-A. Frontiers in Pharmacology. 10. 1297–1297. 21 indexed citations
19.
Jensen, Ole, Muhammad Rafehi, Mladen V. Tzvetkov, & Jürgen Brockmöller. (2019). Stereoselective cell uptake of adrenergic agonists and antagonists by organic cation transporters. Biochemical Pharmacology. 171. 113731–113731. 23 indexed citations
20.
Matthaei, Johannes, et al.. (2018). OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil. Clinical Pharmacology & Therapeutics. 105(1). 190–200. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joao N.S. Pereira Breakdown of academic impact, for papers by Akihiro Inano Breakdown of academic impact, for papers by Ali R. Saadatmand Breakdown of academic impact, for papers by Hélène Chapy Breakdown of academic impact, for papers by Gregory Kaler Breakdown of academic impact, for papers by Renato J. Scialis Breakdown of academic impact, for papers by Naotoshi Yamamura Breakdown of academic impact, for papers by Lucy Sasongko Breakdown of academic impact, for papers by Vincent Tong Breakdown of academic impact, for papers by Philip Worboys
Rankless by CCL
2026